#1 Clinical Trials Search in Europe

Technetium (99Mtc)

Technetium (99mTc) is a radioactive isotope being studied in clinical trials for its potential to improve breast cancer screening, particularly in women with dense breast tissue. This article explores how Technetium (99mTc) is used in molecular breast imaging (MBI) and sentinel lymph node biopsy procedures, offering new hope for more accurate and early detection of breast cancer.

Table of Contents

What is Technetium (99mTc)?

Technetium (99mTc) is a radioactive substance used in medical imaging procedures. It’s not a medication that treats diseases directly, but rather a tool that helps doctors see what’s happening inside your body. The term “99mTc” refers to a specific form of technetium that emits gamma rays, which can be detected by special cameras.[1]

This substance is often used in a form called Technetium (99mTc) sestamibi, which is also known by the brand name Cardiolite. In this form, the technetium is combined with other molecules that help it travel to specific parts of the body.[2]

Uses of Technetium (99mTc)

Technetium (99mTc) is primarily used in a type of medical imaging called nuclear medicine. This involves introducing small amounts of radioactive material into the body to diagnose or treat various conditions. Some of the main uses include:

  • Breast cancer screening: Technetium (99mTc) is used in a procedure called Molecular Breast Imaging (MBI), which can help detect breast cancers, especially in women with dense breast tissue.[1]
  • Locating lymph nodes: It’s used to help surgeons find and remove specific lymph nodes (called sentinel lymph nodes) during breast cancer surgery.[3]
  • Heart imaging: Although not mentioned in the provided studies, Technetium (99mTc) sestamibi is commonly used to examine blood flow in the heart.

How is Technetium (99mTc) Administered?

Technetium (99mTc) is typically given as an injection. The exact method can vary depending on the specific procedure:

  • For breast imaging, it may be injected into a vein.[1]
  • For sentinel lymph node procedures, it’s often injected near the tumor or around the nipple area (called periareolar or peritumoural injection).[3]

The amount used is very small, typically measured in millicuries (mCi), which is a unit of radioactivity. For example, one study used 8 mCi for breast imaging,[1] while another used 0.2 – 0.4 mCi for lymph node detection.[3]

Technetium (99mTc) in Molecular Breast Imaging

Molecular Breast Imaging (MBI) is a newer technique that uses Technetium (99mTc) to detect breast cancers. Here’s how it works:

  1. You receive an injection of Technetium (99mTc) sestamibi.
  2. The substance travels through your bloodstream and tends to accumulate more in cancer cells than in normal cells.
  3. Special cameras detect the gamma rays emitted by the technetium, creating images of your breast tissue.
  4. Areas that show higher concentrations of the technetium may indicate the presence of cancer.

MBI has shown promise in detecting cancers in women with dense breast tissue, where traditional mammograms might miss some tumors. In one study, MBI was able to find additional cancers that weren’t seen on mammograms.[1]

Technetium (99mTc) in Sentinel Lymph Node Biopsy

In breast cancer surgery, it’s important to check if cancer has spread to nearby lymph nodes. Technetium (99mTc) is used to help locate the first lymph node(s) where cancer is likely to spread, called the sentinel lymph node(s). This procedure is called sentinel lymph node biopsy:

  1. Technetium (99mTc) is injected near the tumor or around the nipple.
  2. It travels through the lymphatic system, just as cancer cells would.
  3. A special device detects the radioactivity, helping the surgeon locate the sentinel lymph node(s).
  4. The surgeon can then remove these specific nodes for testing, rather than removing many lymph nodes unnecessarily.

This technique helps minimize the number of lymph nodes that need to be removed, reducing the risk of complications like lymphedema (swelling in the arm).[3]

Safety Considerations

While the idea of a radioactive substance in your body might sound scary, Technetium (99mTc) is generally considered safe when used properly. The amount of radiation is very small and short-lived. However, as with any medical procedure, there are some considerations:

  • Always inform your doctor if you’re pregnant or breastfeeding, as special precautions may be needed.
  • Some people may experience mild side effects like pain at the injection site or allergic reactions, but these are rare.
  • The radiation exposure from these procedures is typically less than what you’d receive from many common X-ray procedures.

Doctors carefully weigh the benefits of using Technetium (99mTc) against any potential risks. If you have concerns, don’t hesitate to discuss them with your healthcare provider.[3]

Aspect Details
Primary Use Breast cancer screening and sentinel lymph node detection
Technique Molecular Breast Imaging (MBI) and sentinel lymph node biopsy
Advantages Higher sensitivity in dense breast tissue, potential for lower false-positive rates
Dosage Varies by study: 8 mCi to 20 mCi for MBI, 0.2 – 0.4 mCi for sentinel lymph node biopsy
Administration Intravenous injection for MBI, periareolar or peritumoural injection for sentinel lymph node biopsy
Ongoing Research Optimizing radiation dose, comparing effectiveness to traditional mammography

FAQ

  • What is Technetium (99mTc) and how is it used in breast cancer screening? Technetium (99mTc) is a radioactive isotope used in nuclear medicine imaging. In breast cancer screening, it's combined with a drug called sestamibi to create a compound that can be detected by special cameras. This technique, called Molecular Breast Imaging (MBI), can help detect breast cancers that might be missed by traditional mammography, especially in women with dense breast tissue.
  • How does Molecular Breast Imaging (MBI) work? MBI involves injecting a small amount of Technetium (99mTc) sestamibi into the body. The compound is then absorbed by breast tissue, with cancerous cells typically absorbing more than healthy cells. Special gamma cameras then create images of the breast, highlighting areas that may contain cancer. This technique can be particularly useful for women with dense breast tissue, where traditional mammograms might miss some cancers.
  • Is MBI using Technetium (99mTc) safe? While MBI does involve exposure to a small amount of radiation, researchers are working to minimize this exposure. Recent studies have focused on using lower doses of Technetium (99mTc) while still maintaining the effectiveness of the screening. As with any medical procedure, the benefits and risks should be discussed with a healthcare provider.
  • How does Technetium (99mTc) compare to traditional mammography? Studies suggest that MBI using Technetium (99mTc) may be more sensitive in detecting breast cancers compared to traditional mammography, especially in women with dense breast tissue. It may also have higher specificity, meaning it could lead to fewer false positive results. However, MBI is typically used as a complementary tool to mammography, not as a replacement.
  • What is the role of Technetium (99mTc) in sentinel lymph node biopsy? In sentinel lymph node biopsy procedures, Technetium (99mTc) can be used to help locate the sentinel lymph nodes – the first lymph nodes where cancer cells are likely to spread. A small amount of the radioactive material is injected near the tumor site, and special detectors are used to track its movement to the sentinel nodes. This helps surgeons identify which lymph nodes should be removed and tested for cancer cells.

Ongoing Clinical Trials on Technetium (99Mtc)

  • Study on Detecting Sentinel Lymph Nodes in Early Oral Cancer Using Gallium-68-Tilmanocept and Technetium-99m in Patients with Oral Cancer

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Diagnosing Vesicoureteral Reflux in Children Using Sulfur Hexafluoride and Technetium (99mTc)

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Finland

  • Study on Sentinel Node Detection Using Technetium-99m and Indocyanine Green in Patients with Early-Stage Ovarian Cancer

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Spain

Glossary

  • Technetium (99mTc) sestamibi: A pharmaceutical agent used in nuclear medicine imaging. It's a combination of the radioactive isotope technetium-99m and a compound called sestamibi, which helps the technetium concentrate in certain tissues.
  • Molecular Breast Imaging (MBI): A nuclear medicine imaging technique that uses a small amount of radioactive tracer and special camera to detect breast cancer, particularly useful in women with dense breast tissue.
  • Dense breast tissue: Breasts that have a high proportion of fibrous or glandular tissue compared to fatty tissue. Dense breasts can make it harder to detect cancer on a standard mammogram.
  • Mammography: An X-ray imaging technique used to screen for breast cancer and other breast abnormalities.
  • Sentinel lymph node: The first lymph node or group of nodes that cancer cells are most likely to spread to from a primary tumor.
  • Specificity: In medical testing, specificity refers to the ability of a test to correctly identify those without the condition (true negative rate).
  • Sensitivity: In medical testing, sensitivity refers to the ability of a test to correctly identify those with the condition (true positive rate).
  • Diagnostic yield: The proportion of patients undergoing a diagnostic test who are found to have the condition for which the test is being performed.
  • Recall rate: The percentage of screening mammograms that require additional imaging or evaluation.
  • Biopsy: A medical procedure that involves taking a small sample of tissue from the body for examination and diagnosis.

References

  1. https://clinicaltrials.gov/study/NCT01925170
  2. https://clinicaltrials.gov/study/NCT00620373
  3. https://clinicaltrials.gov/study/NCT06024213